Profile
Mark W.
Hahn is an Independent Director at ALSP Orchid Acquisition Corp.
I since 2021.
Mr. Hahn is a Director at Opterion Health AG.
Former roles include Independent Director at Soleno Therapeutics, Inc. from 2025 to 2026; Chief Financial Officer at Charles & Colvard Ltd. from 1984 to 1996; Chief Financial Officer, Secretary & Treasurer at Verona Pharma Ltd.; Chief Financial Officer at Equitel, Inc.; Principal at Ernst & Young LLP; Chief Financial Officer at Athenix Corp.
from 2008 to 2009; Chief Financial Officer & VP-Administration at Gigabeam Corp.
from 2007 to 2008; Chief Financial Officer at BuildLinks, Inc. from 2002 to 2007; Chief Financial Officer & Executive Vice President at Cempra Pharmaceuticals, Inc. and Cempra, Inc. from 2010 to 2017; Chief Financial Officer at Performaworks, Inc.; and Chief Financial Officer at Dova Pharmaceuticals, Inc. from 2018 to 2019.
Education includes an undergraduate degree from the University of Wisconsin-Milwaukee conferred in 1984.
Mark Hahn active positions
| Companies | Position | Start |
|---|---|---|
| ALSP ORCHID ACQUISITION CORPORATION I | Director/Board Member | 2021-10-31 |
Opterion Health AG
Opterion Health AG Medical/Nursing ServicesHealth Services Provides chronic kidney disease services | Director/Board Member | - |
Former positions of Mark Hahn
| Companies | Position | End |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Director/Board Member | 2026-05-14 |
| DOVA PHARMACEUTICALS, INC. | Director of Finance/CFO | 2019-11-11 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops medicines for treating drug-resistant bacterial infections | Director of Finance/CFO | 2017-11-29 |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Director of Finance/CFO | 2017-10-31 |
Athenix Corp.
Athenix Corp. Chemicals: AgriculturalProcess Industries Develops agricultural herbicide tolerance and insect control chemicals | Director of Finance/CFO | 2008-12-31 |
Training of Mark Hahn
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Charles & Colvard Ltd.
Charles & Colvard Ltd. Other Consumer SpecialtiesConsumer Durables Manufactures, markets, distributes and sells moissanite jewels | Consumer Durables |
Equitel, Inc.
Equitel, Inc. Specialty TelecommunicationsCommunications Provides prepaid local telephone and cellular phone service | Communications |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Athenix Corp.
Athenix Corp. Chemicals: AgriculturalProcess Industries Develops agricultural herbicide tolerance and insect control chemicals | Process Industries |
Gigabeam Corp.
Gigabeam Corp. Wireless TelecommunicationsCommunications Provides wireless communication solutions | Communications |
BuildLinks, Inc.
BuildLinks, Inc. Packaged SoftwareTechnology Services Develops construction management and scheduling software for home builders | Technology Services |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops medicines for treating drug-resistant bacterial infections | Health Technology |
Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases | Health Technology |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Health Technology |
Performaworks, Inc.
Performaworks, Inc. Packaged SoftwareTechnology Services Provides data processing services | Technology Services |
Verona Pharma Plc
Verona Pharma Plc Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases | Health Technology |
University of Wisconsin-Milwaukee
University of Wisconsin-Milwaukee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dova Pharmaceuticals, Inc.
Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Opterion Health AG
Opterion Health AG Medical/Nursing ServicesHealth Services Provides chronic kidney disease services | Health Services |
ALSP Orchid Acquisition Corp. I
ALSP Orchid Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Stock Market
- Insiders
- Mark Hahn
















